Axel Finckh (A Finckh)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 44

Top Venues

Annals of the rheumatic diseases

RMD open

BMJ open

Journal of clinical medicine

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital

United States

Research fellow :: Rheumatology

CHUV

Switzerland

Chef de Clinique :: Division of Rheumatology

Geneva University Hospital (HUG)

Switzerland

Intern :: Internal Medicine

Publications

Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Cécile Trottet, Ahmed Allam, Aron N Horvath, Axel Finckh, Thomas Hügle, Sabine Adler, Diego Kyburz, Raphael Micheroli, Michael Krauthammer, Caroline Ospelt
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases. PLOS digital health 3 (6) (2024)
Janet E Pope, Axel Finckh, Lucía Silva Fernández, Peter Mandl, Haiyun Fan, Jose L Rivas, Monica Valderrama, Maria Montoro
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention. Open access rheumatology : research and reviews 16 (2024)
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, Kim Lauper, Cédric Laedermann, Clémentine Perrier, Ruediger Mueller, Delphine Sophie Courvoisier, Axel Finckh
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA. BMJ open 14 (3) (2024)
Kim Lauper, Axel Finckh, Stéphane Genevay, Charlotte Girard-Guyonvarc'h, Romain Guemara, Michael John Nissen, Michele Iudici
[Rheumatology: what's new in 2023]. Revue medicale suisse 20 (856-7) (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Benoit Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, Olivia Studer, Delphine Sophie Courvoisier, Jeroen Raes, Axel Finckh
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis. RMD open 10 (1) (2024)
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, Kim Lauper, Cédric Laedermann, Clémentine Perrier, Ruediger Mueller, Delphine Sophie Courvoisier, Axel Finckh
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA. BMJ open 14 (3) (2024)
Janet E Pope, Axel Finckh, Lucía Silva Fernández, Peter Mandl, Haiyun Fan, Jose L Rivas, Monica Valderrama, Maria Montoro
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention. Open access rheumatology : research and reviews 16 (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Cécile Trottet, Ahmed Allam, Aron N Horvath, Axel Finckh, Thomas Hügle, Sabine Adler, Diego Kyburz, Raphael Micheroli, Michael Krauthammer, Caroline Ospelt
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases. PLOS digital health 3 (6) (2024)
Benoit Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, Olivia Studer, Delphine Sophie Courvoisier, Jeroen Raes, Axel Finckh
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis. RMD open 10 (1) (2024)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, Axel Finckh, Thomas Hügle, Andrea M Burden
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab. RMD open 9 (4) (2023)
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, Burkhard Möller, Axel Finckh, Michael John Nissen, Pascale Exer, René Bräm, Diego Kyburz, Andrea Rubbert-Roth, Michael Andor, Xenofon Baraliakos, Manouk de Hooge, Oliver Distler, Almut Scherer, Adrian Ciurea
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical rheumatology (2023)
Peter C Taylor, Cedric Laedermann, Rieke Alten, Eugen Feist, Ernest Choy, Ewa Haladyj, Inmaculada De La Torre, Pascal Richette, Axel Finckh, Yoshiya Tanaka
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience. Journal of clinical medicine 12 (13) (2023)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock, Lene Dreyer, Ori Elkayam, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Güzide Nevsun İnanç, Lianne Kearsley-Fleet, Suleyman Serdar Koca, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ana Rodrigues, Ziga Rotar, Anja Strangfeld, Patrick Verschueren, Rasmus Westermann, Jakub Zavada, Delphine Sophie Courvoisier, Axel Finckh, Kim Lauper
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study). Annals of the rheumatic diseases (2023)
Denis Mongin, Kim Lauper, Axel Finckh, Thomas Frisell, Delphine Sophie Courvoisier
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study. Annals of the rheumatic diseases 81 (5) (2022)
Enriqueta Vallejo-Yagüe, Julia N Pfund, Theresa Burkard, Carole Clair, Raphael Micheroli, Burkhard Möller, Axel Finckh, Andrea Michelle Burden
Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort. PloS one 17 (10) (2022)
Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimmie L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Žiga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B M Landewe, Axel Finckh
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Annals of the rheumatic diseases 81 (6) (2022)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Andrea Michelle Burden
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland. BMJ open 12 (3) (2022)
Axel Finckh, Benoît Gilbert, Bridget Hodkinson, Sang-Cheol Bae, Ranjeny Thomas, Kevin D Deane, Deshiré Alpizar-Rodriguez, Kim Lauper
Global epidemiology of rheumatoid arthritis. Nature reviews. Rheumatology 18 (10) (2022)
Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimme L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Ziga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Robert B M Landewe, Axel Finckh, Sytske Anne Bergstra, Delphine Sophie Courvoisier
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology. RMD open 7 (3) (2022)
Laurette van Boheemen, Marieke M Ter Wee, Marie Falahee, Andrew Filer, Marian van Beers-Tas, Axel Finckh, Aase Hensvold, Karim Raza, Dirkjan van Schaardenburg
The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development. Scandinavian journal of rheumatology (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, Kim Lauper, Denis Mongin, Florenzo Iannone, Karel Pavelka, Dan C Nordström, Güzide Nevsun İnanç, Catalin Codreanu, Kimmie L Hyrich, Denis Choquette, Anja Strangfeld, Burkhard F Leeb, Ziga Rotar, Ana Rodrigues, Eirik Klami Kristianslund, Tore K Kvien, Ori Elkayam, Galina Lukina, Sytske Anne Bergstra, Axel Finckh, Delphine Sophie Courvoisier
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries. Annals of the rheumatic diseases (2022)
Kim Lauper, Michele Iudici, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, René Cordtz, Diederik De Cock, Lene Dreyer, Ori Elkayam, Ellen-Margrethe Hauge, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Nevsun Inanc, Lianne Kearsley-Fleet, Eirik Klami Kristianslund, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Anja Strangfeld, Patrick Verschueren, Delphine Sophie Courvoisier, Axel Finckh
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration. Annals of the rheumatic diseases 81 (10) (2022)
Axel Finckh, Delphine Courvoisier, Celine Lamacchia, null null
Measuring ACPA in the general population or primary care: is it useful? RMD open 6 (1) (2021)
Daniel Manoil, Delphine Sophie Courvoisier, Benoit Gilbert, Burkhard Möller, Ulrich A Walker, Ines Von Muehlenen, Andrea Rubbert-Roth, Axel Finckh, Nagihan Bostanci
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. Rheumatology (Oxford, England) 60 (10) (2021)
Enriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, Raphael Micheroli, Axel Finckh, Andrea Michelle Burden
Primary and secondary non-response: in need of operational definitions in observational studies. Annals of the rheumatic diseases (2021)
Maria Kalweit, Ulrich A Walker, Axel Finckh, Rüdiger Müller, Gabriel Kalweit, Almut Scherer, Joschka Boedecker, Thomas Hügle
Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network. PloS one 16 (6) (2021)
Cathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, Tim Cunningham, Romain Guemara, Laure Brulhart, Diana Dan, Delphine Sophie Courvoisier, Axel Finckh
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab. RMD open 7 (3) (2021)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Burkhard Möller, Axel Finckh, Andrea Michelle Burden
Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland. Journal of clinical medicine 10 (14) (2021)
Yomei Shaw, Delphine S Courvoisier, Almut Scherer, Adrian Ciurea, Thomas Lehmann, Veronika K Jaeger, Ulrich A Walker, Axel Finckh
Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction. RMD open 7 (1) (2021)
Kulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, Deshiré Alpizar-Rodriguez, Anca Irinel Catrina, Juan D Cañete, Andrew P Cope, Claire Immediato Daien, Kevin D Deane, Hani El Gabalawy, Axel Finckh, V Michael Holers, Marios Koloumas, Francesca Ometto, Karim Raza, Condruta Zabalan, Annette H M van der Helm van Mil, Dirkjan van Schaardenburg, Daniel Aletaha, Paul Emery
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the rheumatic diseases 80 (10) (2021)
Theresa Burkard, Ross D Williams, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Diego Kyburz, Andrea Michelle Burden
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients. Rheumatology advances in practice 5 (3) (2021)
Adrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Isabell von Loga, Raphael Micheroli, Burkhard Möller, Andrea Rubbert-Roth, Michael Andor, René Bräm, Angela Müller, Diana Dan, Diego Kyburz, Oliver Distler, Almut Scherer, Axel Finckh
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases 80 (2) (2020)
Deshiré Alpizar-Rodriguez, Axel Finckh, Benoit Thomas P Gilbert
The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development. Nutrients 13 (1) (2020)
Deshiré Alpizar-Rodriguez, Axel Finckh
Is the prevention of rheumatoid arthritis possible? Clinical rheumatology 39 (5) (2020)
Adrian Ciurea, Axel Finckh
Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand et al. Annals of the rheumatic diseases (2020)
Marie Kostine, Axel Finckh, Clifton O Bingham, Karen Visser, Jan Leipe, Hendrik Schulze-Koops, Ernest H Choy, Karolina Benesova, Timothy R D J Radstake, Andrew P Cope, Olivier Lambotte, Jacques-Eric Gottenberg, Yves Allenbach, Marianne Visser, Cindy Rusthoven, Lone Thomasen, Shahin Jamal, Aurélien Marabelle, James Larkin, John B A G Haanen, Leonard H Calabrese, Xavier Mariette, Thierry Schaeverbeke
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Annals of the rheumatic diseases 80 (1) (2020)
Christian Dejaco, Alessia Alunno, Johannes W J Bijlsma, Annelies Boonen, Bernard G Combe, Axel Finckh, Pedro M Machado, Ivan Padjen, Francisca Sivera, Tanja Alexandra Stamm, Frank Buttgereit
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Annals of the rheumatic diseases (2020)
Benoit Thomas P Gilbert, Axel Finckh, Deshiré Alpizar-Rodriguez
Response to: 'Correspondence on 'Prevotella copri in individuals at risk for rheumatoid arthritis'' by Sun and Ni. Annals of the rheumatic diseases (2020)
Deshiré Alpizar-Rodriguez, Axel Finckh
Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid Arthritis. The Journal of rheumatology 47 (2) (2019)

Axel Finckh.css-eqlu8i{font-size:small;padding-left:4px;} (A Finckh)

Publication Activity (10 Years)

Top Topics

Top Venues

Axel Finckh (A Finckh)